Radix Astragali and Radix Rehmanniae, the principal components of two antidiabetic foot ulcer herbal formulae, elicit viability-promoting effects on primary fibroblasts cultured from diabetic foot ulcer tissues

Over 194 million people suffer from diabetes worldwide. The improper control of diabetes may result in diabetic foot ulcer or even amputation. Herbal medicine provides a means for treating diabetic foot ulcers for a large population in developing countries. The wound healing-enhancing activities of...

Full description

Saved in:
Bibliographic Details
Published in:Phytotherapy research Vol. 23; no. 6; pp. 809 - 815
Main Authors: Lau, T.W, Chan, Y.W, Lau, C.P, Lau, K.M, Lau, C.B.S, Fung, K.P, Leung, P.C, Ho, Y.Y
Format: Journal Article
Language:English
Published: Chichester, UK John Wiley & Sons, Ltd 01-06-2009
Wiley
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Over 194 million people suffer from diabetes worldwide. The improper control of diabetes may result in diabetic foot ulcer or even amputation. Herbal medicine provides a means for treating diabetic foot ulcers for a large population in developing countries. The wound healing-enhancing activities of the principal herbs, Radix Astragali (RA) and Radix Rehmanniae (RR) in two clinically efficacious Chinese herbal formulae were studied in primary fibroblasts from diabetic foot ulcer patients. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay showed that RA and RR significantly enhanced the viability of fibroblasts isolated from foot ulcers of diabetic patients, even from those with no response to insulin treatment. The results in this study indicate that fibroblast viability enhancement effects of RA and RR likely underlie the healing effects of F1 and F2 in diabetic foot ulcers. Copyright © 2009 John Wiley & Sons, Ltd.
Bibliography:http://dx.doi.org/10.1002/ptr.2649
University Grants Committee of the Hong Kong Special Administrative Region, China under the Area of Excellence project 'Chinese Medicine Research and Further Development' - No. AoE/B-10/01
istex:5A5FE398EBAF7EACA715F62B620349550D4C86AB
ark:/67375/WNG-W1M3D369-J
ArticleID:PTR2649
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0951-418X
1099-1573
DOI:10.1002/ptr.2649